Correspondence 0001193125-25-014246 from Beta Bionics, Inc. (BBNX)
Beta Bionics, Inc.
Date: Jan. 28, 2025 · CIK: 0001674632 · Accession: 0001193125-25-014246
AI Filing Summary & Sentiment
File numbers found in text: 333-284147
Letter
Beta Bionics, Inc.
11 Hughes
Irvine, CA 92618
January 28, 2025
VIA EDGAR
Office of Industrial Applications and Services
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Juan Grana, Lauren Nguyen, Julie Sherman and Jeanne Baker
Re: Beta Bionics, Inc.
Registration Statement on Form S-1, as amended (File No. 333-284147)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Beta Bionics, Inc. (the “Company”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on Form S-1 (as amended to date, the “Registration Statement”) and declare the Registration Statement effective as of 4:00 p.m. Eastern time, on January 29, 2025, or as soon thereafter as possible, or at such other time as its legal counsel, Cooley LLP, may request by telephone to the staff of the Commission.
Once the Registration Statement has been declared effective, please orally confirm that event with Carlos Ramirez of Cooley LLP at (858) 550-6157 or, in his absence, Charles S. Kim of Cooley LLP at (858) 550-6049.
Under separate cover, you will receive today a letter from the managing underwriters of the proposed offering joining in the Company’s request for acceleration of the effectiveness of the Registration Statement.
Very truly yours,
Beta Bionics, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Beta Bionics, Inc. 11 Hughes Irvine, CA 92618 January 28, 2025 VIA EDGAR Office of Industrial Applications and Services Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attn: Juan Grana, Lauren Nguyen, Julie Sherman and Jeanne Baker Re: Beta Bionics, Inc. Registration Statement on Form S-1, as amended (File No. 333-284147) Request for Acceleration of Effective Date Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Beta Bionics, Inc. (the “Company”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on Form S-1 (as amended to date, the “Registration Statement”) and declare the Registration Statement effective as of 4:00 p.m. Eastern time, on January 29, 2025, or as soon thereafter as possible, or at such other time as its legal counsel, Cooley LLP, may request by telephone to the staff of the Commission. Once the Registration Statement has been declared effective, please orally confirm that event with Carlos Ramirez of Cooley LLP at (858) 550-6157 or, in his absence, Charles S. Kim of Cooley LLP at (858) 550-6049. Under separate cover, you will receive today a letter from the managing underwriters of the proposed offering joining in the Company’s request for acceleration of the effectiveness of the Registration Statement. Very truly yours, Beta Bionics, Inc. /s/ Sean Saint By: Sean Saint Title: President and Chief Executive Officer cc: Stephen Feider, Chief Financial Officer, Beta Bionics, Inc. Carlos Ramirez, Cooley LLP Charles S. Kim, Cooley LLP Mark Weeks, Cooley LLP Nathan Ajiashvili, Latham & Watkins LLP Ross McAloon, Latham & Watkins LLP Matthew T. Bush, Latham & Watkins LLP